Jeff Fairman

1.2k total citations
44 papers, 914 citations indexed

About

Jeff Fairman is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Jeff Fairman has authored 44 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Jeff Fairman's work include Viral gastroenteritis research and epidemiology (6 papers), Acute Myeloid Leukemia Research (6 papers) and Immunotherapy and Immune Responses (5 papers). Jeff Fairman is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), Acute Myeloid Leukemia Research (6 papers) and Immunotherapy and Immune Responses (5 papers). Jeff Fairman collaborates with scholars based in United States, Netherlands and Malawi. Jeff Fairman's co-authors include Peter C. Nowell̀, David F. Claxton, Liang Hong, L Nagarajan, Lalitha Nagarajan, Eric D. Green, Neeraj Kapoor, Steven Dow, Ilya Chumakov and A. Craig Chinault and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jeff Fairman

43 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Fairman United States 19 368 208 187 185 182 44 914
Fin J. Milder Netherlands 10 302 0.8× 444 2.1× 72 0.4× 128 0.7× 226 1.2× 13 813
Yongshui Fu China 23 334 0.9× 331 1.6× 837 4.5× 227 1.2× 240 1.3× 120 1.8k
Anna Flace Switzerland 8 553 1.5× 670 3.2× 126 0.7× 94 0.5× 135 0.7× 10 1.3k
Giuseppina Li Pira Italy 20 248 0.7× 740 3.6× 361 1.9× 218 1.2× 165 0.9× 84 1.2k
Federica Andreoni Switzerland 14 281 0.8× 91 0.4× 119 0.6× 269 1.5× 278 1.5× 33 932
Stephen Henry New Zealand 24 757 2.1× 231 1.1× 153 0.8× 611 3.3× 180 1.0× 97 1.6k
Edmund J. Gosselin United States 21 683 1.9× 1.0k 4.9× 242 1.3× 104 0.6× 281 1.5× 51 1.9k
Tara M. Robinson United States 15 348 0.9× 790 3.8× 250 1.3× 257 1.4× 165 0.9× 47 1.3k
Zoltán Bánki Austria 20 171 0.5× 670 3.2× 148 0.8× 61 0.3× 195 1.1× 48 1.0k
Sarah Murdoch United Kingdom 8 274 0.7× 262 1.3× 78 0.4× 54 0.3× 69 0.4× 8 901

Countries citing papers authored by Jeff Fairman

Since Specialization
Citations

This map shows the geographic impact of Jeff Fairman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Fairman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Fairman more than expected).

Fields of papers citing papers by Jeff Fairman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Fairman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Fairman. The network helps show where Jeff Fairman may publish in the future.

Co-authorship network of co-authors of Jeff Fairman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Fairman. A scholar is included among the top collaborators of Jeff Fairman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Fairman. Jeff Fairman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turbyfill, K. Ross, et al.. (2025). A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system. npj Vaccines. 10(1). 6–6. 1 indexed citations
2.
3.
4.
5.
Bjånes, Elisabet, Zhen Wang, Nina M. van Sorge, et al.. (2023). The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a Peptidase. Vaccines. 11(12). 1811–1811. 1 indexed citations
6.
7.
Kapoor, Neeraj, Satoshi Uchiyama, Melissa H. Wong, et al.. (2022). Non-Native Amino Acid Click Chemistry-Based Technology for Site-Specific Polysaccharide Conjugation to a Bacterial Protein Serving as Both Carrier and Vaccine Antigen. ACS Omega. 7(28). 24111–24120. 18 indexed citations
8.
Fairman, Jeff, Paresh Agarwal, Peter Davey, et al.. (2021). 1047. Development of a Next Generation 30+ Valent Pneumococcal Conjugate Vaccine (VAX-XP) Using Site-Specific Carrier Protein Conjugation. Open Forum Infectious Diseases. 8(Supplement_1). S615–S615. 3 indexed citations
9.
Radvák, Peter, Hyung‐Joon Kwon, Martina Košíková, et al.. (2021). SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Nature Communications. 12(1). 6559–6559. 58 indexed citations
10.
Ndungo, Esther, Andrea G. Buchwald, Neeraj Kapoor, et al.. (2021). Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis. Frontiers in Immunology. 12. 725129–725129. 15 indexed citations
11.
Rocha, Fernanda Regina Godoy, Shirin Ghods, Neeraj Kapoor, et al.. (2021). A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss. SHILAP Revista de lepidopterología. 2. 686402–686402. 10 indexed citations
12.
13.
Carroll, Timothy D., Shannon R. Matzinger, Peter Barry, et al.. (2013). Efficacy of Influenza Vaccination of Elderly Rhesus Macaques Is Dramatically Improved by Addition of a Cationic Lipid/DNA Adjuvant. The Journal of Infectious Diseases. 209(1). 24–33. 18 indexed citations
14.
Troyer, Ryan M., et al.. (2009). Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Vaccine. 27(33). 4424–4433. 25 indexed citations
15.
Chang, Stella, John F. Warner, Lily Liang, & Jeff Fairman. (2009). A novel vaccine adjuvant for recombinant flu antigens. Biologicals. 37(3). 141–147. 22 indexed citations
16.
Fairman, Jeff, et al.. (2009). Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study. Human Vaccines. 5(3). 141–150. 21 indexed citations
17.
Gowen, Brian B., Jeff Fairman, Steven Dow, et al.. (2008). Prophylaxis with cationic liposome–DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs. Antiviral Research. 81(1). 37–46. 18 indexed citations
18.
Ambs, Stefan, et al.. (1999). Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.. PubMed. 59(22). 5773–7. 25 indexed citations
19.
Antillón, Federico, Susana C. Raimondi, Jeff Fairman, et al.. (1998). 5q− in a Child with Refractory Anemia with Excess Blasts. Cancer Genetics and Cytogenetics. 105(2). 119–122. 6 indexed citations
20.
Fairman, Jeff, et al.. (1994). Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm.. Genome Research. 4(1). 6–12. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fin J. Milder Breakdown of academic impact, for papers by Yongshui Fu Breakdown of academic impact, for papers by Anna Flace Breakdown of academic impact, for papers by Giuseppina Li Pira Breakdown of academic impact, for papers by Federica Andreoni Breakdown of academic impact, for papers by Stephen Henry Breakdown of academic impact, for papers by Edmund J. Gosselin Breakdown of academic impact, for papers by Tara M. Robinson Breakdown of academic impact, for papers by Zoltán Bánki Breakdown of academic impact, for papers by Sarah Murdoch
Rankless by CCL
2026